Search for: "SCHERING-PLOUGH"
Results 121 - 140
of 404
Sorted by Relevance
|
Sort by Date
22 May 2012, 5:14 pm
See In Re: Schering Plough Corp. [read post]
31 Aug 2007, 12:53 am
Schering-Plough Defends Suits Over Marketing of 'Off-Label' Drug Uses
New Jersey Law Journal
Schering-Plough Corp. faces a spate of federal court litigation over promotion of its drugs for uses not approved by the Food and Drug Administration. [read post]
7 Apr 2010, 9:14 am
Last year, we had Schering-Plough Corp. v. [read post]
16 Jun 2011, 8:08 am
Schering-Plough Healthcare Products, Inc. v. [read post]
13 Nov 2008, 2:25 pm
NuvaRing The NuvaRing (often misspelled as Nuva Ring or Newva Ring) is a low-dose hormonal, contraceptive device manufactured by Organon, a Dutch pharmaceutical company that was purchased last year by Schering Plough (which sells well known products such as Dr. [read post]
2 Nov 2007, 6:37 am
” In re Schering Marketing & Sales Prac. [read post]
2 Sep 2008, 11:57 am
``This can't help'' the drug's sales, Gordon Tomaselli, a spokesman for the American Heart Association and a cardiologist at Johns Hopkins University School of Medicine in Baltimore, said in an interview at the European Society of Cardiology conference in Munich today.Source.By accessing this site, you are agreeing to comply with and be bound by the terms of use agreement and privacy policy. [read post]
15 Jan 2008, 12:02 am
Plaintiffs Lawyers Split $9.5M Fee in Shareholder Suit Against Schering-Plough
New Jersey Law Journal
A federal judge approved a settlement Monday in a shareholders' derivative suit against Schering-Plough Corp. with no award of damages but a $9.5 million fee to plaintiffs counsel and a company pledge to reform its governance. [read post]
10 Dec 2007, 3:41 am
Both drug are marketed and sold by Schering-Plough and Merck.Cardiologists have been demanding Schering-Plough and Merck come forward with clinical trials to prove the drugs' effectiveness and safety. [read post]
22 Dec 2011, 4:15 pm
., Schering-Plough Corporation, Organon USA, Inc., and N.V. [read post]
17 Jan 2014, 7:01 am
Although the certification procedure serves structural goals such as federalism and “preserv[ing] state sovereignty,” Schering-Plough Healthcare Prods. v. [read post]
21 Dec 2011, 6:01 pm
., Schering Plough Corp., Organon USA, Inc., N.V. [read post]
13 Jul 2009, 9:28 pm
A tip of the old cyberhat - and not for the first time - to Alan Modlinger at Lowenstein Sandler for passing along to us the latest good news on the off-label promotion front - dismissal (with leave to replead under Twombly) in In re Schering-Plough Corp. [read post]
25 Mar 2013, 1:30 pm
March 2013 Rulings By New Jersey Judge Martinotti And NuvaRing MDL Judge Sippel On Expert Witness Testimony Issues All Go In Favor Of Plaintiffs (Posted by Tom Lamb at DrugInjuryWatch.com)According to the Merck 2012 Annual Report / Form 10-K, at page 110, there were approximately 1,315 NuvaRing cases filed against Organon, Schering-Plough, and Merck at the start of January 2013, with about 1,105 of those NuvaRing lawsuits being part of the federal court NuvaRing MDL. [read post]
19 Mar 2007, 6:31 am
Schering-Plough, a similar case was presented to the Supreme Court. [read post]
1 Dec 2009, 8:03 am
It remains to be seen how this strategy will play out here for Schering-Plough. [read post]
2 Jan 2007, 5:03 am
Merpel wonders whether Hoffmann-La Roche and Schering Plough will also be in a congratulatory mood, or whether they will be considering their legal options on purposive construction and equivalents. [read post]
15 Aug 2011, 6:01 am
Schering-Plough Corp., 2011 WL 3452398 (Cal.App. 2 Dist.) [read post]
18 Dec 2013, 2:13 pm
The plaintiffs contend that Organon and Schering-Plough, among other things, failed to adequately design and manufacture NuvaRing and failed to adequately warn of the alleged increased risk of venous thromboembolism (“VTE”) posed by NuvaRing, and/or downplayed the risk of VTE. [read post]
28 Dec 2009, 7:57 am
Schering-Plough recently merged with Merck, and is now known as Merck & Co.California's $21.3 million agreement is one of three settlements negotiated with Schering-Plough, collectively totaling $69 million, over falsely inflated drug prices. [read post]
